A rising PSA after surgery or radiation can be frightening. Learn what biochemical recurrence means, which tests come next and your treatment options. For many men, the first good PSA test after ...
A prospective study of 24 men found that 18F-Flotufolastat PSMA PET MRI detected recurrent prostate cancer in 25 percent of ...
Prostate cancer grows slowly, and while 50% of men on active surveillance eventually need treatment, waiting can mean years without side effects. Men newly diagnosed with prostate cancer face a range ...
Rishi Sunak fears prostate cancer screening decision made over flawed data model - The committee decided against rolling out ...
An international phase 3 clinical trial that treated patients with high-risk localized and locally advanced prostate cancer ...
A radioactive treatment for advanced prostate cancer produced encouraging results in routine French medical practice, ...
Prostate-specific membrane antigen (PSMA)-targeted radiopharmaceutical therapy is safe and effective for patients with ...
Five-year results from the NRG-GU003 Phase III trial show that a 25-fraction, five-week postoperative radiation schedule ...
Amazon S3 on MSN
Alpha therapy linked to strong responses in prostate cancer
A new alpha-emitting radiation therapy, 212Pb-ADVC001, showed strong early results in advanced prostate cancer in a ...
A new alpha-emitting radiopharmaceutical therapy (RPT) for advanced prostate cancer was well tolerated, with no dose-limiting ...
New substudy results showed a 51% lower estimated risk of metastasis or death over time with perioperative apalutamide plus ADT compared with immediate ...
JNJ-6143 is an investigational, once-daily, novel, small molecule designed to trigger cancer cell death through a targeted dual-protein lock between BRD4 and androgen receptor, a highly expressed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results